Parathyroidectomy Versus Cinacalcet Hydrochloride–Based Medical Therapy in the Management of Hyperparathyroidism in ESRD: A Cost Utility Analysis

Background Previously, patients with end-stage renal disease (ESRD) with uncontrolled hyperparathyroidism had few options other than parathyroidectomy, which was reserved for patients refractory to medical therapy. Newer calcimimetic agents, such as cinacalcet, may be an alternative, but raise the p...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of kidney diseases 2007-06, Vol.49 (6), p.801-813
Hauptverfasser:	Narayan, Rajeev, MD, Perkins, Robert M., MD, Berbano, Elizabeth P., MD, MPH, Yuan, Christina M., MD, Neff, Robert T., MD, Sawyers, Eric S., MD, Yeo, Fred E., MD, Vidal-Trecan, Gwenaelle M., MD, PhD, Abbott, Kevin C., MD, MPH
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biological and medical sciences Cinacalcet Hydrochloride cost utility Cost-Benefit Analysis cost-effectiveness Decision Trees Endocrinopathies Female Humans hyperparathyroidism Hyperparathyroidism - drug therapy Hyperparathyroidism - economics Hyperparathyroidism - etiology Hyperparathyroidism - surgery Hyperparathyroidism - therapy Kidney Failure, Chronic - complications Kidney Failure, Chronic - economics Male Medical decision analysis Medical sciences Middle Aged Naphthalenes - economics Naphthalenes - therapeutic use Nephrology Nephrology. Urinary tract diseases Nephropathies. Renovascular diseases. Renal failure Non tumoral diseases. Target tissue resistance. Benign neoplasms parathyroid hormone (PTH) Parathyroidectomy Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases) Quality-Adjusted Life Years Renal failure Time Factors United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!